These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22213328)

  • 1. Expression of prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cells.
    Thill M; Hoellen F; Becker S; Dittmer C; Fischer D; Kümmel S; Salehin D; Friedrich M; Köster F; Diedrich K; Cordes T
    Anticancer Res; 2012 Jan; 32(1):367-72. PubMed ID: 22213328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of calcitriol on prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cell lines.
    Thill M; Cordes T; Hoellen F; Becker S; Dittmer C; Kümmel S; Salehin D; Friedrich M; Diedrich K; Köster F
    Anticancer Res; 2012 Jan; 32(1):359-65. PubMed ID: 22213327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.
    Thill M; Fischer D; Becker S; Cordes T; Dittmer C; Diedrich K; Salehin D; Friedrich M
    Anticancer Res; 2009 Sep; 29(9):3619-25. PubMed ID: 19667157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer.
    Cordes T; Hoellen F; Dittmer C; Salehin D; Kümmel S; Friedrich M; Köster F; Becker S; Diedrich K; Thill M
    Anticancer Res; 2012 Jan; 32(1):351-7. PubMed ID: 22213326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.
    Thill M; Fischer D; Hoellen F; Kelling K; Dittmer C; Landt S; Salehin D; Diedrich K; Friedrich M; Becker S
    Anticancer Res; 2010 May; 30(5):1673-9. PubMed ID: 20592360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prostaglandin metabolising enzymes COX-2 and 15-PGDH and VDR in human granulosa cells.
    Thill M; Becker S; Fischer D; Cordes T; Hornemann A; Diedrich K; Salehin D; Friedrich M
    Anticancer Res; 2009 Sep; 29(9):3611-8. PubMed ID: 19667156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
    de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
    Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
    BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and malignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostaglandin E2 (PGE2) serum level in ovarian cancer patients.
    Thill M; Fischer D; Kelling K; Hoellen F; Dittmer C; Hornemann A; Salehin D; Diedrich K; Friedrich M; Becker S
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):387-90. PubMed ID: 20304053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine metabolism of vitamin D in normal and malignant breast tissue.
    Townsend K; Banwell CM; Guy M; Colston KW; Mansi JL; Stewart PM; Campbell MJ; Hewison M
    Clin Cancer Res; 2005 May; 11(9):3579-86. PubMed ID: 15867263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
    Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
    J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D, calcidiol and calcitriol regulate vitamin D metabolizing enzymes in cervical and ovarian cancer cells.
    Kloss M; Fischer D; Thill M; Friedrich M; Cordes T; Salehin D; Diedrich K; Köster F
    Anticancer Res; 2010 Nov; 30(11):4429-34. PubMed ID: 21115889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues.
    Suetani RJ; Ho K; Jindal S; Manavis J; Neilsen PM; Pishas KI; Rippy E; Bochner M; Kollias J; Gill PG; Morris HA; Callen DF
    Mol Cell Endocrinol; 2012 Oct; 362(1-2):202-10. PubMed ID: 22750718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract.
    Blomberg Jensen M; Nielsen JE; Jørgensen A; Rajpert-De Meyts E; Kristensen DM; Jørgensen N; Skakkebaek NE; Juul A; Leffers H
    Hum Reprod; 2010 May; 25(5):1303-11. PubMed ID: 20172873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.
    Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.
    Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E
    Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D metabolism in mammary gland and breast cancer.
    Welsh J
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):55-60. PubMed ID: 21669251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.